34 min
#CKD with Tom Collings of Kalium Health Cambridge Tech Podcast
-
- Business
Founding CEO Tom Collings talks to us about Kalium Health and managing kidney disease.
Did you know that 800 million people are affected by kidney disease around the world, costing $2 billion to manage kidney disease in US alone?
Tom talks to us about:
· His background as an engineer, to helping startups, to building a company
· Founding the company with three amazing women – Fiona Karet, Tanya Hutter, Liz Norgett,
· His tips to ‘just do it, life is too short to watch for the side lines’ and bringing others along on the journey
· Following Andy Richards well-known narrative that “Cambridge is a low-risk place to do high risk things”
· Manufacturing in Cambridge at prototype scale to get the product into the hands of clinics and clinical services, launching initially in the US
· Initial funding from Cambridge investors – Cambridge Angels, Martlet Capital – any timely opportunities for new professional investors during 2024
· We talk about medical insight and scientific innovation from an original idea to clinical trials.
Tune in to hear all of this, and much more.
Produced by Cambridge TV
Hosted on Acast. See acast.com/privacy for more information.
Founding CEO Tom Collings talks to us about Kalium Health and managing kidney disease.
Did you know that 800 million people are affected by kidney disease around the world, costing $2 billion to manage kidney disease in US alone?
Tom talks to us about:
· His background as an engineer, to helping startups, to building a company
· Founding the company with three amazing women – Fiona Karet, Tanya Hutter, Liz Norgett,
· His tips to ‘just do it, life is too short to watch for the side lines’ and bringing others along on the journey
· Following Andy Richards well-known narrative that “Cambridge is a low-risk place to do high risk things”
· Manufacturing in Cambridge at prototype scale to get the product into the hands of clinics and clinical services, launching initially in the US
· Initial funding from Cambridge investors – Cambridge Angels, Martlet Capital – any timely opportunities for new professional investors during 2024
· We talk about medical insight and scientific innovation from an original idea to clinical trials.
Tune in to hear all of this, and much more.
Produced by Cambridge TV
Hosted on Acast. See acast.com/privacy for more information.
34 min